-
公开(公告)号:US20130040914A1
公开(公告)日:2013-02-14
申请号:US13639954
申请日:2011-04-04
IPC分类号: A61K31/675 , A61K31/444 , C07D471/04 , C07F9/6561 , A61P31/18
CPC分类号: C07D471/04 , C07F9/6561
摘要: Compounds of Formula I are described: (I), wherein RP and RQ are defined herein. The compounds transcriptase, the prophylaxis and treatment of infection by HIV, and the prophylaxis, delay in the onset or progression, and treatment of AIDS. The compounds can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines.
摘要翻译: 描述了式I化合物:(I),其中RP和RQ在本文中定义。 化合物转录酶,艾滋病毒感染的预防和治疗以及艾滋病的预防,延迟发作或进展和治疗。 该化合物可以用作药物组合物中的成分,任选地与其它抗病毒剂,免疫调节剂,抗生素或疫苗组合使用。
-
公开(公告)号:US08404856B2
公开(公告)日:2013-03-26
申请号:US12742159
申请日:2008-11-14
申请人: Thomas J. Tucker , Robert Tynebor , John T. Sisko , Neville Anthony , Robert Gomez , Samson M. Jolly
发明人: Thomas J. Tucker , Robert Tynebor , John T. Sisko , Neville Anthony , Robert Gomez , Samson M. Jolly
IPC分类号: C07D403/00 , C07D401/00
CPC分类号: C07D401/06 , C07D471/04
摘要: Heteroaromatic compounds of Formula (I) are HIV reverse transcriptase inhibitors, wherein ring A is: (ii-a), (ii-b), (ii-c), (ii-d), or (ii-e); and wherein n, L, M, U, X, Y, Z, RE, RF, R1, R2A, R2B, R2C, R3, R8, R9 and R10 are defined herein. The compounds of Formula I and their pharmaceutically acceptable salts and prodrugs are useful in the inhibition of HIV reverse transcriptase, the prophylaxis and treatment of infection by HIV and in the prophylaxis, delay in the onset or progression, and treatment of AIDS. The compounds and their salts and prodrugs can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines.
摘要翻译: 式(I)的杂芳族化合物是HIV逆转录酶抑制剂,其中环A是:(ii-a),(ii-b),(ii-c),(ii-d)或(ii-e); 并且其中n,L,M,U,X,Y,Z,RE,RF,R1,R2A,R2B,R2C,R3,R8,R9和R10在本文中定义。 式I化合物及其药学上可接受的盐和前药可用于抑制HIV逆转录酶,预防和治疗HIV感染以及预防,延缓发病或进展以及AIDS治疗。 化合物及其盐和前药可以用作药物组合物中的成分,任选与其它抗病毒剂,免疫调节剂,抗生素或疫苗组合使用。
-
公开(公告)号:US20100256181A1
公开(公告)日:2010-10-07
申请号:US12742159
申请日:2008-11-14
申请人: Thomas J. Tucker , Robert Tynebor , John T. Sisko , Neville Anthony , Robert Gomez , Samson M. Jolly
发明人: Thomas J. Tucker , Robert Tynebor , John T. Sisko , Neville Anthony , Robert Gomez , Samson M. Jolly
IPC分类号: A61K31/444 , C07D471/04 , A61P31/18
CPC分类号: C07D401/06 , C07D471/04
摘要: Heteroaromatic compounds of Formula (I) are HIV reverse transcriptase inhibitors, wherein ring A is: (ii-a), (ii-b), (ii-c), (ii-d), or (ii-e); and wherein n, L, M, U, X, Y, Z, RE, RF, R1, R2A, R2B, R2C, R3, R8, R9 and R10 are defined herein. The compounds of Formula I and their pharmaceutically acceptable salts and prodrugs are useful in the inhibition of HIV reverse transcriptase, the prophylaxis and treatment of infection by HIV and in the prophylaxis, delay in the onset or progression, and treatment of AIDS. The compounds and their salts and prodrugs can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines.
摘要翻译: 式(I)的杂芳族化合物是HIV逆转录酶抑制剂,其中环A是:(ii-a),(ii-b),(ii-c),(ii-d)或(ii-e); 并且其中n,L,M,U,X,Y,Z,RE,RF,R1,R2A,R2B,R2C,R3,R8,R9和R10在本文中定义。 式I化合物及其药学上可接受的盐和前药可用于抑制HIV逆转录酶,预防和治疗HIV感染以及预防,延缓发病或进展以及AIDS治疗。 化合物及其盐和前药可以用作药物组合物中的成分,任选与其它抗病毒剂,免疫调节剂,抗生素或疫苗组合使用。
-
4.
公开(公告)号:US07332499B2
公开(公告)日:2008-02-19
申请号:US10565040
申请日:2004-08-03
申请人: Neville J. Anthony , Robert Gomez , Samson M. Jolly , John Jin Lim , Dai-shi Su
发明人: Neville J. Anthony , Robert Gomez , Samson M. Jolly , John Jin Lim , Dai-shi Su
IPC分类号: A61K31/505 , A61K31/12 , C07D417/00 , C07D239/00 , C07C233/00
CPC分类号: C07D213/82 , C07C307/02 , C07C309/65 , C07C309/66 , C07C309/67 , C07C309/76 , C07C311/09 , C07C311/46 , C07C2601/02 , C07D215/58 , C07D239/28 , C07D417/12
摘要: N-(Sulfonyloxybiarylmethyl) aminocyclopropanecarboxamide derivatives are bradykinin B1 antagonists or inverse agonists useful in the treatment or prevention of symptoms such as pain and inflammation associated with the bradykinin B1 pathway.
摘要翻译: N-(磺酰氧基联芳基甲基)氨基环丙烷甲酰胺衍生物是缓激肽B1拮抗剂或反激动剂,其可用于治疗或预防与缓激肽B1途径相关的疼痛和炎症等症状。
-
公开(公告)号:US20080275097A1
公开(公告)日:2008-11-06
申请号:US11999686
申请日:2007-12-06
申请人: Neville J. Anthony , Robert Gomez , Samson M. Jolly , Dai-Shi Su , John Lim
发明人: Neville J. Anthony , Robert Gomez , Samson M. Jolly , Dai-Shi Su , John Lim
IPC分类号: A61K31/41 , A61P31/18 , C07D231/54 , C07D235/04 , A61K31/4164 , C07D255/04 , A61K31/415
CPC分类号: C07D471/04 , C07D231/54 , C07D249/18
摘要: Compounds of Formula I: are HIV reverse transcriptase inhibitors, wherein V, W, X, Y, Z, R1, R2, R4, R5, R6, ring A, ring B, j and k are defined herein. The compounds of Formula I, and the pharmaceutically acceptable salts and prodrugs thereof, are useful in the inhibition of HIV reverse transcriptase, the prophylaxis and treatment of infection by HIV and in the prophylaxis, delay in the onset or progression, and treatment of AIDS. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines.
摘要翻译: 式I化合物是HIV逆转录酶抑制剂,其中V,W,X,Y,Z,R 1,R 2,R 4, R 5,R 6,环A,环B,j和k如本文所定义。 式I化合物及其药学上可接受的盐和前药可用于抑制HIV逆转录酶,预防和治疗HIV感染以及预防,延缓发病或进展以及AIDS治疗。 化合物及其盐可以用作药物组合物中的成分,任选与其它抗病毒剂,免疫调节剂,抗生素或疫苗组合使用。
-
6.
公开(公告)号:US20060247229A1
公开(公告)日:2006-11-02
申请号:US10565040
申请日:2004-08-03
申请人: Neville Anthony , Robert Gomez , Samson Jolly , John Lim , Dai-shi Su
发明人: Neville Anthony , Robert Gomez , Samson Jolly , John Lim , Dai-shi Su
IPC分类号: A61K31/54 , A61K31/505 , A61K31/18
CPC分类号: C07D213/82 , C07C307/02 , C07C309/65 , C07C309/66 , C07C309/67 , C07C309/76 , C07C311/09 , C07C311/46 , C07C2601/02 , C07D215/58 , C07D239/28 , C07D417/12
摘要: N-(Sulfonyloxybiarylmethyl)aminocyclopropanecarboxamide derivatives are bradykinin B1 antagonists or inverse agonists useful in the treatment or prevention of symptoms such as pain and inflammation associated with the bradykinin B1 pathway.
摘要翻译: N-(磺酰氧基联芳基甲基)氨基环丙烷甲酰胺衍生物是缓激肽B1拮抗剂或反激动剂,其可用于治疗或预防与缓激肽B1途径相关的疼痛和炎症等症状。
-
公开(公告)号:US20050176718A1
公开(公告)日:2005-08-11
申请号:US11056412
申请日:2005-02-11
申请人: Neville Anthony , Robert Gomez , Steven Young , Melissa Egbertson , John Wai , Linghang Zhuang , Mark Embrey , Lekhanh Tran , Jeffrey Melamed , H. Langford , James Guare , Thorsten Fisher , Samson Jolly , Michelle Kuo , Debra Perlow , Jennifer Bennett , Timothy Funk
发明人: Neville Anthony , Robert Gomez , Steven Young , Melissa Egbertson , John Wai , Linghang Zhuang , Mark Embrey , Lekhanh Tran , Jeffrey Melamed , H. Langford , James Guare , Thorsten Fisher , Samson Jolly , Michelle Kuo , Debra Perlow , Jennifer Bennett , Timothy Funk
IPC分类号: A61K31/4375 , A61K31/47 , A61K31/4985 , A61K31/541 , A61K31/554 , A61P31/12 , A61P31/18 , C07D20060101 , C07D215/48 , C07D221/00 , C07D241/00 , C07D471/00 , C07D471/04 , C07D471/16 , C07D487/00 , C07D519/00 , A61K31/498 , A61K31/4745 , C07D471/02 , C07D487/02
CPC分类号: C07D471/04
摘要: Aza- and polyaza-naphthalenyl carboxamide derivatives including certain quinoline carboxamide and naphthyridine carboxamide derivatives are described. These compounds are inhibitors of HIV integrase and inhibitors of HIV replication, and are useful in the prevention or treatment of infection by HIV and the treatment of AIDS, as compounds or pharmaceutically acceptable salts, or as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of preventing, treating or delaying the onset of AIDS and methods of preventing or treating infection by HIV are also described.
-
公开(公告)号:US20100286192A1
公开(公告)日:2010-11-11
申请号:US12839807
申请日:2010-07-20
申请人: Neville J. Anthony , Robert Gomez
发明人: Neville J. Anthony , Robert Gomez
IPC分类号: A61K31/437 , A61K31/4709 , A61P31/18
CPC分类号: C07D471/04 , C07D231/54 , C07D249/18
摘要: Compounds of Formula I: are HIV reverse transcriptase inhibitors, wherein V, W, X, Y, Z, R1, R2, R4, R5, R6, ring A, ring B, j and k are defined herein. The compounds of Formula I, and the pharmaceutically acceptable salts and prodrugs thereof, are useful in the inhibition of HIV reverse transcriptase, the prophylaxis and treatment of infection by HIV and in the prophylaxis, delay in the onset or progression, and treatment of AIDS. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines.
摘要翻译: 式I化合物是HIV逆转录酶抑制剂,其中V,W,X,Y,Z,R 1,R 2,R 4,R 5,R 6,环A,环B,j和k如本文所定义。 式I化合物及其药学上可接受的盐和前药可用于抑制HIV逆转录酶,预防和治疗HIV感染以及预防,延缓发病或进展以及AIDS治疗。 化合物及其盐可以用作药物组合物中的成分,任选与其它抗病毒剂,免疫调节剂,抗生素或疫苗组合使用。
-
公开(公告)号:US07781454B2
公开(公告)日:2010-08-24
申请号:US11999686
申请日:2007-12-06
申请人: Neville J. Anthony , Robert Gomez
发明人: Neville J. Anthony , Robert Gomez
IPC分类号: A01N43/42 , A61K31/44 , A61K31/415 , C07D471/02 , C07D491/02 , C07D498/02 , C07D213/56
CPC分类号: C07D471/04 , C07D231/54 , C07D249/18
摘要: Compounds of Formula I: are HIV reverse transcriptase inhibitors, wherein V, W, X, Y, Z, R1, R2, R4, R5, R6, ring A, ring B, j and k are defined herein. The compounds of Formula I, and the pharmaceutically acceptable salts and prodrugs thereof, are useful in the inhibition of HIV reverse transcriptase, the prophylaxis and treatment of infection by HIV and in the prophylaxis, delay in the onset or progression, and treatment of AIDS. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines.
摘要翻译: 式I化合物是HIV逆转录酶抑制剂,其中V,W,X,Y,Z,R 1,R 2,R 4,R 5,R 6,环A,环B,j和k如本文所定义。 式I化合物及其药学上可接受的盐和前药可用于抑制HIV逆转录酶,预防和治疗HIV感染以及预防,延缓发病或进展以及AIDS治疗。 化合物及其盐可以用作药物组合物中的成分,任选与其它抗病毒剂,免疫调节剂,抗生素或疫苗组合使用。
-
公开(公告)号:US5029694A
公开(公告)日:1991-07-09
申请号:US430678
申请日:1989-11-01
申请人: Robert Gomez
发明人: Robert Gomez
IPC分类号: B65G47/52 , B65G47/248 , B65G47/252 , B65G47/74
CPC分类号: B65G47/252 , B65G2201/0244 , B65G2207/14
摘要: An erecting device for bottles transported in recumbent position by a rope conveyor rotates the bottles to an upright position and deposits them on an apron conveyor which is positioned at a lower level at the end of the rope conveyor. The erecting device includes a pulley having two outer flanges, a pair of washers between the flanges and a pair of deformable rubber disks between the washers for holding a bottle during rotation from the recumbent to the vertical position. Each outer flange is connected to the rotating pulley axle by a respective intermediate cotter. The cotters are adjustably translatable along the length of the pulley axle such that the spacing between the rubber disks is adjustable to accommodate different bottle dimensions.
摘要翻译: 用于通过绳索传送器在卧式运输中运输的瓶子的竖立装置将瓶子旋转到直立位置,并将它们沉积在位于绳索输送机端部的较低水平的围裙输送机上。 竖立装置包括具有两个外部凸缘的滑轮,在凸缘之间的一对垫圈和垫圈之间的一对可变形的橡胶盘,用于在从卧式旋转到垂直位置时保持瓶子。 每个外凸缘通过相应的中间开口连接到旋转滑轮轴。 开口沿着皮带轮轴的长度可调节地平移,使得橡胶盘之间的间隔是可调节的,以适应不同的瓶子尺寸。
-
-
-
-
-
-
-
-
-